在接受重症监护病房治疗的ARDS患者中,30天死亡率的预测模型
Fengjuan Jia1, Guodong Xia2, Lirong Hu1
1Department of Critical Care Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan Province, China.
European journal of medical research
|July 3, 2025
概括
这项研究开发了一种新型的诺姆图,用于预测急性呼吸困扰综合征 (ARDS) 的重症监护病房 (ICU) 患者的30天死亡率. 该模型具有良好的预测价值,可以帮助早期风险分层,以便及时进行干预.
科学领域:
- 关键护理医学 关键护理医学
- 呼吸系统医学 呼吸系统医学
- 生物统计学 生物统计学
背景情况:
- 急性呼吸窘迫综合征 (ARDS) 的高住院死亡率为40%,对医疗保健造成重大负担.
- 现有的重症监护治疗对降低ARDS死亡率的影响有限.
- 准确预测死亡率对于有效的ICU患者管理至关重要.
研究的目的:
- 开发和验证一种名谱,用于预测ARDS诊断的重症监护病房 (ICU) 患者的30天死亡率.
- 确定与ARDS患者30天死亡率相关的关键临床因素.
- 将开发模型的预测性能与已建立的严重性评分系统进行比较.
主要方法:
- 利用了来自MIMIC-IV数据库的4920名ARDS患者和来自西南医学大学附属医院的248名ARDS患者的数据.
- 使用相关性分析,热图,LASSO回归用于风险因素选,以及多变量后勤回归来构建预测模型.
- 在内部和外部验证该模型,并将其有效性与SOFA,APS-III,OASIS和SAPS-II分数进行比较.
主要成果:
- 开发的名图实现了曲线下的面积 (AUC) 为0.78.
- 内部验证显示AUC为0.805,外部验证显示AUC为0.742.
- 与传统的评分系统 (OASIS,SAPS-II,APS-III和SOFA) 相比,该模型显示出更高的预测效率.
结论:
- 通过使用可访问的临床数据,成功建立了ICU入院ARDS患者的30天死亡风险预测模型.
- 开发了一个开放式移动应用程序,用于实时床边风险分层,增强临床效用.
- 该模型有助于早期识别高风险ARDS患者,补充现有的评分系统,并指导及时干预.
相关概念视频
Acute Respiratory Failure-II
377
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
377
Acute Respiratory Failure-IV
238
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
238
Acute Respiratory Failure-V
214
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
214
Acute Respiratory Failure-I
345
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
345
Acute Respiratory Failure-III
335
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
335


